Ledipasvir/sofosbuvir is effective and well tolerated in postkidney transplant patients with chronic hepatitis C virus-Reference-Cited by-同舟云学术

Ledipasvir/sofosbuvir is effective and well tolerated in postkidney transplant patients with chronic hepatitis C virus

Published:2017-03-25 Issue:5 Volume:31 Page:e12941
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Morales Amilcar L.¹^ORCID,Liriano-Ward Luz²,Tierney Amber³,Sang Michelle¹,Lalos Alexander¹,Hassan Mohamed³,Nair Vinay²^ORCID,Schiano Thomas⁴,Satoskar Rohit¹,Smith Coleman¹

Affiliation:

1. Transplant Hepatology Service; Medstar Georgetown University Hospital; Washington DC USA

2. Division of Nephrology; Icahn School of Medicine at Mount Sinai; New York NY USA

3. Division of Gastroenterology Hepatology and Nutrition; University of Minnesota; Minneapolis MN USA

4. Division of Liver Diseases; Icahn School of Medicine at Mount Sinai; New York NY USA

Funder

Gilead Sciences

Merck

Publisher

Wiley

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ctr.12941/fullpdf

Reference42 articles.

1. Hepatitis C virus infection and kidney transplantation in 2014: what's new?;Baid-Agrawal;Am J Transplant,2014

2. The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment;Terrault;Clin J Am Soc Nephrol,2007

3. Epidemiology and clinical significance of hepatotropic infections in dialysis patients. Recent evidence;Fabrizi;Minerva Urol Nefrol,2004

4. Serum alanine aminotransferase in hepatitis c screening of patients on hemodialysis;Saab;Am J Kidney Dis,2001

5. The prevalence and incidence of hepatitis C virus infections among dialysis patients in the Netherlands: a nationwide prospective study;Schneeberger;J Infect Dis,2000

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world effectiveness of genotype-specific and pangenotypic direct-acting antivirals in HCV-infected patients with renal failure;Clinical and Experimental Hepatology;2023

2. ‘Real-life’ experience with direct-acting antiviral agents for HCV after kidney transplant;Annals of Hepatology;2021-11

3. Real-world direct-acting antiviral treatment in kidney transplant and hemodialysis patients: the EpiTer-2 multicenter observational study;Annals of Gastroenterology;2021

4. Eradication of hepatitis C virus infection in kidney transplant recipients using direct‐acting antiviral therapy: Qatar experience;Immunity, Inflammation and Disease;2020-12-02

5. Review: Evaluation and Management of the HIV/HCV Co-Infected Kidney or Liver Transplant Candidate;CURR TREAT OPT INFEC;2020